Project Grant R21NS143251
Award Date
6/9/25
Completion Date
5/31/27
Dollars Obligated
$461K
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,841,367.00 to The Regents of the University of California, San Francisco to conduct research on understanding the role of the TBK1 protein kinase in regulating selective autophagy pathways in neurons. The goal is to gain a comprehensive understanding of how disruption of TBK1 function leads to the loss of excitatory neurons, which is a key feature of frontotemporal dementia (FTD)...
This $871,093 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Sloan-Kettering Institute for Cancer Research supports research to elucidate the mechanisms underlying the regulation of the transcription factor TFEB and the autophagy-lysosomal pathway, and to investigate their therapeutic potential as treatments for Alzheimer's disease. The key objectives are to study how the protein phosphatases CDC25A and PP2A regulate TFEB signaling and the...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $104,164 to Emory University to investigate the interaction between the TMEM106B gene and the C9ORF72 gene, which are both linked to frontotemporal dementia (FTD) and other neurodegenerative disorders. The research aims to determine how the TMEM106B protein interacts with the dipeptide repeat proteins produced by the C9ORF72 gene mutation, and to examine the toxicity of...
This $1,086,563 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research conducted by the University of Pennsylvania to investigate the regulation of autophagy and lysosomal pathways in neurons and astrocytes under proteotoxic stress associated with alpha-synucleinopathies. The research aims to define the sequence of degradation of alpha-synuclein fibrils via lysosome-mediated pathways within astrocytes compared to neurons, as well as the role...
This federal Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to define the mechanisms that coordinate late endosome and lysosome functions across the size and polarity of neurons. The $605,486 grant, awarded on January 1, 2025, will fund research at Yale University to address the lack of understanding regarding how the network of proteins that control lysosome function is integrated to support the unique demands of neurons. The research...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,001,864 to Harvard University to investigate the subcellular mechanisms underlying the selective vulnerability of specific neuron subtypes in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will quantitatively study the localization of RNA, proteins, and translational regulation in the synapses and soma of vulnerable corticospinal neurons (CSN) and...
The National Institute on Aging (NIA) awarded a $1,275,512 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) to investigate the impact of progranulin species on the clearance of TDP-43 protein in neurodegenerative disorders such as Alzheimer's disease, frontotemporal dementia, and limbic-predominant age-associated TDP-43 encephalopathy. The 2-year grant, with a start date of June 1, 2025, aims to...
This $146,922 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by The Johns Hopkins University to investigate physiological pathways that modulate tau protein homeostasis, with potential implications for Alzheimer's disease and related dementias. The key objectives are to: 1) Examine how the loss of the GDE2 protein affects the onset and progression of neurodegeneration, tau modifications, and aggregation in an animal model and...
This $460,625 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to investigate the roles of the deubiquitylation pathway in TDP-43 pathology related to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The award, provided to the University of Massachusetts Medical School, will utilize mouse models and...
This $1,592,854 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by the University of Illinois to understand the biological mechanisms underlying neurodegenerative tauopathy diseases, including Alzheimer's disease. The project aims to define how modifications to the tau protein, such as phosphorylation and other post-translational changes, can disrupt its normal scaffolding functions and lead to the dysregulation of critical...